why can't they focus on commercialising the skin patches and then work on the bigger stuff? At least start making some money. Or is it not ready for that yet?
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive
